CN116421170A - Intelligent monitoring watch suitable for asthma patient and use method thereof - Google Patents
Intelligent monitoring watch suitable for asthma patient and use method thereof Download PDFInfo
- Publication number
- CN116421170A CN116421170A CN202310485451.8A CN202310485451A CN116421170A CN 116421170 A CN116421170 A CN 116421170A CN 202310485451 A CN202310485451 A CN 202310485451A CN 116421170 A CN116421170 A CN 116421170A
- Authority
- CN
- China
- Prior art keywords
- patient
- watch
- pef
- module
- shell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000006673 asthma Diseases 0.000 title claims abstract description 69
- 238000012544 monitoring process Methods 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 25
- 238000007664 blowing Methods 0.000 claims abstract description 23
- 238000006243 chemical reaction Methods 0.000 claims abstract description 16
- 238000005259 measurement Methods 0.000 claims abstract description 7
- 238000001514 detection method Methods 0.000 claims description 23
- 239000003814 drug Substances 0.000 claims description 22
- 230000000694 effects Effects 0.000 claims description 16
- 208000024891 symptom Diseases 0.000 claims description 15
- 229940079593 drug Drugs 0.000 claims description 13
- 230000004199 lung function Effects 0.000 claims description 13
- 201000010099 disease Diseases 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
- 230000000241 respiratory effect Effects 0.000 claims description 9
- 238000012216 screening Methods 0.000 claims description 9
- 230000006870 function Effects 0.000 claims description 8
- 240000007651 Rubus glaucus Species 0.000 claims description 6
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 6
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 6
- 230000002354 daily effect Effects 0.000 claims description 6
- 210000004072 lung Anatomy 0.000 claims description 6
- 230000001105 regulatory effect Effects 0.000 claims description 6
- 206010008479 Chest Pain Diseases 0.000 claims description 4
- 206010011224 Cough Diseases 0.000 claims description 4
- 208000037656 Respiratory Sounds Diseases 0.000 claims description 4
- 206010047924 Wheezing Diseases 0.000 claims description 4
- 238000005452 bending Methods 0.000 claims description 3
- 229940124630 bronchodilator Drugs 0.000 claims description 3
- 239000000168 bronchodilator agent Substances 0.000 claims description 3
- 238000004891 communication Methods 0.000 claims description 3
- 239000000599 controlled substance Substances 0.000 claims description 3
- 238000011161 development Methods 0.000 claims description 3
- 230000007613 environmental effect Effects 0.000 claims description 3
- 230000003203 everyday effect Effects 0.000 claims description 3
- 230000006872 improvement Effects 0.000 claims description 3
- 238000007689 inspection Methods 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 230000000422 nocturnal effect Effects 0.000 claims description 3
- 239000010939 rose gold Substances 0.000 claims description 3
- 229910001112 rose gold Inorganic materials 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 210000003437 trachea Anatomy 0.000 claims description 3
- 230000003442 weekly effect Effects 0.000 claims description 3
- 230000001154 acute effect Effects 0.000 abstract description 3
- 230000004202 respiratory function Effects 0.000 abstract description 3
- 230000036541 health Effects 0.000 description 8
- 238000011282 treatment Methods 0.000 description 7
- 210000000707 wrist Anatomy 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 230000002265 prevention Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
- 238000011369 optimal treatment Methods 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000024716 acute asthma Diseases 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/087—Measuring breath flow
- A61B5/0871—Peak expiratory flowmeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/02108—Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
- A61B5/681—Wristwatch-type devices
-
- A—HUMAN NECESSITIES
- A63—SPORTS; GAMES; AMUSEMENTS
- A63B—APPARATUS FOR PHYSICAL TRAINING, GYMNASTICS, SWIMMING, CLIMBING, OR FENCING; BALL GAMES; TRAINING EQUIPMENT
- A63B23/00—Exercising apparatus specially adapted for particular parts of the body
- A63B23/18—Exercising apparatus specially adapted for particular parts of the body for improving respiratory function
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02D—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN INFORMATION AND COMMUNICATION TECHNOLOGIES [ICT], I.E. INFORMATION AND COMMUNICATION TECHNOLOGIES AIMING AT THE REDUCTION OF THEIR OWN ENERGY USE
- Y02D30/00—Reducing energy consumption in communication networks
- Y02D30/70—Reducing energy consumption in communication networks in wireless communication networks
Abstract
The invention discloses an intelligent monitoring watch suitable for asthmatic patients and a use method thereof, wherein the intelligent monitoring watch comprises a dial plate and a watchband, the dial plate comprises a shell, a screen, a blowing nozzle, a knob, keys, a charging port and a control circuit board; the screen is arranged on the front side surface of the shell, the blowing nozzle is arranged below the screen, the blowing nozzle is rotationally connected with the dial plate through a rotating shaft, the knob is arranged on the right side surface of the shell, the keys are arranged on the left side surface of the shell, and the control circuit board is arranged in the shell; the control circuit board comprises a processor, a Bluetooth module, an AD conversion module, a pressure sensor, a potentiometer sensor, a photoelectric sensor, an indication module, a storage module and a power module; according to the invention, the peak flow velocity meter is combined with the intelligent watch, the peak flow velocity of the expired breath of the patient suffering from asthma, namely PEF measurement, is used for monitoring the degree of the severity of the asthma, so that early warning is achieved, the frequency of acute attack of the asthma is effectively reduced, and the patient is assisted to perform respiratory function exercise.
Description
Technical Field
The invention relates to the technical field of intelligent monitoring watches, in particular to an intelligent monitoring watch suitable for asthmatic patients and a use method thereof.
Background
Bronchial asthma, abbreviated as asthma, is a common chronic inflammatory disease of the airways, and patients often present with reversible airflow limitation. Epidemiological studies at home and abroad show that the prevalence of asthma has increased year by year in recent years.
During the period of asthma attack, patients often have cough, wheezing, chest distress, shortness of breath and other symptoms, and often repeatedly attack, and have obvious negative effects on the quality of life. Thus, early discovery, early treatment, early prevention are the principles that asthma should always follow. There is much evidence that administration of asthma management of pulmonary function and inflammation can reduce the risk of asthma attacks, as patients often fail to properly perceive exacerbations of asthma symptoms. Common indicators of lung function examination in asthmatic patients are first second expiratory volume FEV1 and maximum expiratory Peak flow Peak ExpiratoryFlow, PEF. The lung function of the patient can be objectively and accurately judged by using the lung function instrument. However, the lung function detection device used in hospitals is expensive and requires professional operation, and cannot meet the requirement of dynamically monitoring the change of the lung function of a patient. PEF refers to the highest flow rate of the patient when exhaling hard, has good correlation with FEV1, and can better reflect the patency of the airway. The PEF can be conveniently and rapidly measured through a simple peak flow rate meter, is an important index for a doctor to judge the severity of the disease of a patient and the treatment effect of the disease, and provides a timely and objective basis for adjusting the medication and analyzing the disease control condition. The global asthma prevention and treatment counseling GINA and the national bronchial asthma prevention and treatment guideline take PEF as important indexes for diagnosing asthma and grading the severity of illness, and the illness state of an asthmatic patient can be graded more accurately by combining the clinical symptoms and the PEF value measured by a peak flow rate meter, and the patient in the attack stage can be better found by combining the record of PEF with the grading evaluation of an asthmatic diary, so that the treatment is carried out early, and the method has positive significance for relieving the illness state of the patient. For patients suffering from acute asthma, the PEF value obtained by the peak flow velocity meter can better reflect the condition control condition of the patients, a simple and easy self-monitoring method is provided for the patients, the patients can find the worsening phenomenon of asthma as soon as possible, and the attacks are prevented.
Therefore, an intelligent monitoring watch suitable for asthmatic patients and a using method thereof are urgent to be solved.
Disclosure of Invention
The invention aims to solve the technical problems that the lung function detection equipment used in hospitals is high in price and needs professional operation, and the requirements of dynamically monitoring the lung function change of patients can not be met; the existing household peak flow velocity meter has the technical problems of convenience in carrying part, inaccurate recording, no cloud end and no warning.
In order to solve the technical problems, the technical scheme provided by the invention is as follows: an intelligent monitoring watch suitable for asthma patients comprises a dial plate and a watchband, wherein the dial plate comprises a shell, a screen, a blowing nozzle, a knob, keys, a charging port and a control circuit board; the screen is arranged on the front side surface of the shell, the blowing nozzle is arranged below the screen, the blowing nozzle is rotationally connected with the dial plate through a rotating shaft, the knob is arranged on the right side surface of the shell, the key is arranged on the left side surface of the shell, the charging port is arranged on the rear side surface of the shell, and the control circuit board is arranged in the shell;
the control circuit board comprises a processor, a Bluetooth module, an AD conversion module, a pressure sensor, a potentiometer sensor, a photoelectric sensor, an indication module, a storage module and a power module, wherein the output end of the pressure sensor is electrically connected with the input end of the potentiometer sensor, the output end of the potentiometer sensor and the output end of the photoelectric sensor are respectively electrically connected with the input end of the AD conversion module, the output end of the AD conversion module is electrically connected with the input end of the processor, the output end of the processor is respectively electrically connected with the input end of the indication module, the input end of the storage module and the input end of a screen, the power module provides power required by the intelligent monitoring watch, and the charging port is electrically connected with the power module;
the watch is characterized in that a watch buckle is arranged on the watch strap, the watch strap comprises a first watch strap and a second watch strap, one end of the first watch strap is connected with the dial plate, the other end of the first watch strap is connected with the watch buckle, one end of the second watch strap is connected with the dial plate, and the other end of the second watch strap penetrates through the watch buckle.
Further, the shell is provided with a placing groove, the rotating shaft is arranged at the bottom of the placing groove, and the blowing nozzle is clamped on the rotating shaft and is detachably connected with the rotating shaft.
Further, the pressure sensor is arranged on the rotating shaft, and when the blowing nozzle rotates to be vertical to the dial plate, the pressure sensor appears at the bottom of the blowing nozzle; the photoelectric sensor is arranged on the rear side surface of the shell.
Further, the dial plate bottom is provided with a first fixing buckle, the dial plate top is provided with a second fixing buckle, one end of the first watchband is fixed in the first fixing buckle, and one end of the second watchband is fixed in the second fixing buckle.
Further, the shell is made of rose gold frosted metal.
Furthermore, the processor adopts a raspberry group convenient for agile development, and the Bluetooth module is a Bluetooth communication module on the SOC of the raspberry group; the processor sends control data to the mobile terminal through the Bluetooth module; the storage module is used for storing an SD card; the indication module is used for indicating by an LED lamp; the AD conversion module is a PCF8591AD module; the pressure sensor is a resistive film pressure sensor.
Further, the mobile terminal comprises a patient end, a medical care end and a relative end.
The use method of the intelligent monitoring watch comprises the following steps of:
the method for detecting the lung function of a patient is as follows:
and (3) primary detection: when the patient detects for the first time, the patient needs to be filled with the sex, the height and the age of the patient, so that the normal PEF value of the patient is obtained;
the correct detection method comprises the following steps: when the device is used for detection, a standing position and a sitting position are adopted, a subject rapidly and deeply sucks one breath to the total lung amount position, the mouth of the subject is rapidly contained in the mouth and is tightly covered by the lips, no air leakage is avoided, and the gas in the lung is immediately exhaled by using the maximum strength and the maximum speed; the whole expiration is finished at one time, the middle part cannot be stopped, the neck keeps a neutral position, and the trachea is prevented from being pressed due to the forward bending and backward tilting of the neck; checking for at least 3 times, if the difference between the measured values of 3 times is too large, paying attention to whether the checking method is correct or not, repeating for a plurality of times, so that the difference between the optimal 3 times is less than 5%, or the difference between the measured values of the optimal 2 times in 3 times is less than 40L/min, and taking the highest value as PEF;
detection time: routine inspection: detecting for 2 times in day and night, and after getting up and before sleeping; checking as required: measuring when the symptom appears in the subject, and measuring before and after the exercise and the environmental factor exposure stimulus respectively; checking before and after administration: PEF was measured before and after inhalation of the quick-acting bronchodilators, and the PEF was monitored for days and weeks using controlled drug to assess airway reversibility and drug efficacy;
detecting the effect of PEF on expiratory airflow limitation:
judging by adopting the percentage of the PEF actual measurement value to the normal predicted value, if the PEF is more than or equal to 80 percent of the predicted value, prompting that the PEF is normal or has no expiratory airflow limitation, and distinguishing that the asthma of the patient is well controlled as a green area; PEF accounts for 60% -80% of the expected value, and indicates that the light-moderate expiratory airflow is limited, and the patient has asthma symptoms, and if the patient has symptoms of nocturnal attack, cough, chest distress, wheezing and limited activity, the medication is regulated according to the situation; PEF accounts for less than 60% of the expected value, and indicates that the expiratory airflow limitation degree is heavy, and the expiratory airflow limitation is red, so that the patient has asthma symptoms at rest and limited activity and needs to take medicine immediately;
detecting the effect of PEF variability on variable expiratory airflow limitation:
daily detection: screening measured PEFs every 24 hours to obtain PEFMAX and PEFMIN, and calculating to obtain a daily variation rate PEF24 hours; if PEF24h is less than 10%, sending 'your disease control is stable' to the patient end; if PEF24h is more than 10%, sending 'your condition is unstable, and suggesting to increase one medicine inhalation'; if PEF24h is more than 20%, sending' your illness state is unstable, suggesting to increase one medicine inhalation, and suggesting to consult doctors;
weekly testing: screening the measured PEFs for 1 week to obtain PEF24hMAX and PEF24hMIN, and calculating to obtain Zhou Bianyi-rate PEF1wk; if PEF1wk is less than 10%, sending 'your disease control is stable, and a doctor can be consulted to adjust the dosage' to a patient end; if PEF1wk is more than 10%, sending a 'maintaining current medication' to a patient end;
monthly detection: screening the measured PEF1wk for 1 month to obtain PEF1wkMAX and PEF1wkMIN, calculating to obtain a month variation rate PEF1mon, and if the PEF1mon is less than 10%, sending a patient xx to be regulated medication to a doctor terminal; if PEF1mon is more than 20%, sending ' unstable illness state ' to a patient end, and consulting with a doctor as soon as possible ';
detecting and reminding functions:
according to the state of illness of patients, adjusting the interval time T of each breath detection amount examination; if the patient respiratory gas quantity is not detected in the T, sending a proposal of measuring the maximum respiratory gas quantity as soon as possible to an intelligent bracelet end and sending the proposal to a mobile terminal of the patient or family members;
respiratory exercise function:
the expected vital capacity is set according to the weight, sex and age of the patient, and the patient can train and punch cards every day according to the expected vital capacity, so that the improvement of the lung function is promoted.
Further, the predicted formula of the PEF value is as follows:
the adult formula is: male: PEFL/min=76.5+20.4×a-0.41×a2+0.002×a3+1.19×h
Female: PEFL/min=282.0+1.79×a-0.046×a2+0.68×h
The formula for children is: male: PEFL/min=5.29×h-427.1
Female: PEFL/min=4.94×h-399.8
Wherein A refers to age, and the unit is age; h refers to height in cm.
Compared with the prior art, the invention has the advantages that: according to the invention, the blow nozzle and the pressure sensor for monitoring the peak flow velocity are arranged on the watch, a person to be tested blows air into the blow nozzle by force to enable the pressure sensor to read a certain pressure, and accurate measurement of the peak flow velocity is realized by continuous experimental calibration; collecting pulse waveforms of the wrist part by adopting a photoelectric sensor, and calculating to obtain blood pressure information of a patient according to a formula; according to the invention, the peak flow velocity meter is combined with the intelligent watch, the peak flow velocity of the expired breath of the patient suffering from asthma, namely PEF measurement, is used for monitoring the degree of the severity of the asthma, so that early warning is achieved, the frequency of acute attack of the asthma is effectively reduced, and the patient is assisted to perform respiratory function exercise.
The wrist strap is convenient to wear and high in comfort, is suitable for wrists with different thicknesses, and reduces uncomfortable feeling for asthma patients; the invention has the capability of monitoring the physical condition of the asthmatic patient with high precision; the asthma-relieving health care product has the advantages that the asthma-relieving health care product is instant, the asthma patient needs to be helped in time during the attack period, and the asthma-relieving health care product can immediately detect and remind the patient or relatives and friends and medical staff; the watch is connected with the mobile terminal to transmit the monitored data to medical staff or relatives and friends so that the medical staff or relatives and friends can know the health condition of the patient at any time and adjust the treatment scheme in real time; the invention has individuation, provides individuation monitoring and reminding functions according to the illness state degree and the incentive of the asthma patient, so as to achieve the optimal treatment effect; the invention has stronger durability, the battery life of the watch needs to be long enough, and the watch can stably work in the long-time use process, thereby reducing the frequency of battery replacement or charging; the invention has reasonable design and is worth popularizing.
Drawings
Fig. 1 is a schematic structural diagram of an intelligent watch suitable for asthmatic patients according to the present invention.
Fig. 2 is a schematic structural diagram of a smart watch for asthmatic patients according to the second embodiment of the present invention.
Fig. 3 is a schematic diagram of a smart watch for asthmatic patients according to the present invention.
Fig. 4 is a schematic diagram of the structure of a dial in an intelligent watch suitable for asthmatic patients according to the present invention.
Fig. 5 is a schematic block diagram of a control circuit board in a smart watch adapted for use with asthmatic patients in accordance with the present invention.
As shown in the figure: 1. dial plate, 2, watchband, 3, casing, 4, screen, 5, blowing nozzle, 6, knob, 7, button, 8, charging port, 9, control circuit board, 10, pivot, 11, processor, 12, bluetooth module, 13, AD conversion module, 14, pressure sensor, 15, photoelectric sensor, 16, instruction module, 17, storage module, 18, power module, 19, watch knot, 20, first watchband, 21, second watchband, 22, standing groove, 23, first fixed knot, 24, second fixed knot, 25, potentiometer sensor.
Detailed Description
The invention relates to an intelligent monitoring watch suitable for asthma patients and a use method thereof, and further provides a detailed description of the intelligent monitoring watch and the use method thereof.
The present invention will be described in detail with reference to fig. 1 to 5.
An intelligent monitoring watch suitable for asthma patients comprises a dial plate 1 and a watchband 2, wherein the dial plate 1 comprises a shell 3, a screen 4, a blowing nozzle 5, a knob 6, keys 7, a charging port 8 and a control circuit board 9; the screen 4 is arranged on the front side surface of the shell 3, the blowing nozzle 5 is arranged below the screen 4, the blowing nozzle 5 is rotationally connected with the dial 1 through a rotating shaft 10, the knob 6 is arranged on the right side surface of the shell 3, the key 7 is arranged on the left side surface of the shell 3, the charging port 8 is arranged on the rear side surface of the shell 3, and the control circuit board 9 is arranged in the shell 3;
the control circuit board 9 comprises a processor 11, a Bluetooth module 12, an AD conversion module 13, a pressure sensor 14, a potentiometer sensor 25, a photoelectric sensor 15, an indication module 16, a storage module 17 and a power module 18, wherein the output end of the pressure sensor 14 and the input end of the potentiometer sensor are electrically connected, the output end of the potentiometer sensor and the output end of the photoelectric sensor 15 are respectively and electrically connected with the input end of the AD conversion module 13, the output end of the AD conversion module 13 is electrically connected with the input end of the processor 11, the output end of the processor 11 is respectively and electrically connected with the input end of the indication module 16, the input end of the storage module 17 and the input end of the screen 4, the power module 18 provides power for the intelligent monitoring watch, and the charging port 8 is electrically connected with the power module 18;
the watch band 2 is provided with a watch buckle 19, the watch band 2 comprises a first watch band 20 and a second watch band 21, one end of the first watch band 20 is connected with the dial 1, the other end of the first watch band is connected with the watch buckle 19, one end of the second watch band 21 is connected with the dial 1, and the other end of the second watch band penetrates through the watch buckle 19.
The shell 3 is provided with a placing groove 22, the rotating shaft 10 is arranged at the bottom of the placing groove 22, and the blowing nozzle 5 is clamped on the rotating shaft 10 and is detachably connected with the rotating shaft 10.
The pressure sensor 14 is arranged on the rotating shaft 10, and when the blowing nozzle 5 rotates to be vertical to the dial 1, the pressure sensor 14 appears at the bottom of the blowing nozzle 5; the photoelectric sensor 15 is disposed on the rear side of the housing 3.
The bottom of the dial 1 is provided with a first fixing buckle 23, the top of the dial 1 is provided with a second fixing buckle 24, one end of the first watchband 20 is fixed in the first fixing buckle 23, and one end of the second watchband 21 is fixed in the second fixing buckle 24.
The shell 3 is made of rose gold frosted metal.
The processor 11 adopts a raspberry group convenient for agile development, and the Bluetooth module 12 is a Bluetooth communication module on the raspberry group SOC; the processor 11 transmits control data to the mobile terminal through the Bluetooth module; the storage module 17 is used for storing an SD card; the indication module 16 is used for indicating an LED lamp; the AD conversion module 13 is a PCF8591AD module; the pressure sensor 14 is a resistive thin film pressure sensor.
The mobile terminal comprises a patient end, a medical care end and a relatives end.
The use method of the intelligent monitoring watch comprises the following steps of:
the method for detecting the lung function of a patient is as follows:
and (3) primary detection: when the patient detects for the first time, the patient needs to be filled with the sex, the height and the age of the patient, so that the normal PEF value of the patient is obtained;
the correct detection method comprises the following steps: when the device is used for detection, a standing position and a sitting position are adopted, a subject rapidly and deeply sucks one breath to the total lung amount position, the mouth of the subject is rapidly contained in the mouth and is tightly covered by the lips, no air leakage is avoided, and the gas in the lung is immediately exhaled by using the maximum strength and the maximum speed; the whole expiration is finished at one time, the middle part cannot be stopped, the neck keeps a neutral position, and the trachea is prevented from being pressed due to the forward bending and backward tilting of the neck; checking for at least 3 times, if the difference between the measured values of 3 times is too large, paying attention to whether the checking method is correct or not, repeating for a plurality of times, so that the difference between the optimal 3 times is less than 5%, or the difference between the measured values of the optimal 2 times in 3 times is less than 40L/min, and taking the highest value as PEF;
detection time: routine inspection: detecting for 2 times in day and night, and after getting up and before sleeping; checking as required: measuring when the symptom appears in the subject, and measuring before and after the exercise and the environmental factor exposure stimulus respectively; checking before and after administration: PEF was measured before and after inhalation of the quick-acting bronchodilators, and the PEF was monitored for days and weeks using controlled drug to assess airway reversibility and drug efficacy;
detecting the effect of PEF on expiratory airflow limitation:
judging by adopting the percentage of the PEF actual measurement value to the normal predicted value, if the PEF is more than or equal to 80 percent of the predicted value, prompting that the PEF is normal or has no expiratory airflow limitation, and distinguishing that the asthma of the patient is well controlled as a green area; PEF accounts for 60% -80% of the expected value, and indicates that the light-moderate expiratory airflow is limited, and the patient has asthma symptoms, and if the patient has symptoms of nocturnal attack, cough, chest distress, wheezing and limited activity, the medication is regulated according to the situation; PEF accounts for less than 60% of the expected value, and indicates that the expiratory airflow limitation degree is heavy, and the expiratory airflow limitation is red, so that the patient has asthma symptoms at rest and limited activity and needs to take medicine immediately;
detecting the effect of PEF variability on variable expiratory airflow limitation:
daily detection: screening measured PEFs every 24 hours to obtain PEFMAX and PEFMIN, and calculating to obtain a daily variation rate PEF24 hours; if PEF24h is less than 10%, sending 'your disease control is stable' to the patient end; if PEF24h is more than 10%, sending 'your condition is unstable, and suggesting to increase one medicine inhalation'; if PEF24h is more than 20%, sending' your illness state is unstable, suggesting to increase one medicine inhalation, and suggesting to consult doctors;
weekly testing: screening the measured PEFs for 1 week to obtain PEF24hMAX and PEF24hMIN, and calculating to obtain Zhou Bianyi-rate PEF1wk; if PEF1wk is less than 10%, sending 'your disease control is stable, and a doctor can be consulted to adjust the dosage' to a patient end; if PEF1wk is more than 10%, sending a 'maintaining current medication' to a patient end;
monthly detection: screening the measured PEF1wk for 1 month to obtain PEF1wkMAX and PEF1wkMIN, calculating to obtain a month variation rate PEF1mon, and if the PEF1mon is less than 10%, sending a patient xx to be regulated medication to a doctor terminal; if PEF1mon is more than 20%, sending ' unstable illness state ' to a patient end, and consulting with a doctor as soon as possible ';
detecting and reminding functions:
according to the state of illness of patients, adjusting the interval time T of each breath detection amount examination; if the patient respiratory gas quantity is not detected in the T, sending a proposal of measuring the maximum respiratory gas quantity as soon as possible to an intelligent bracelet end and sending the proposal to a mobile terminal of the patient or family members;
respiratory exercise function:
the expected vital capacity is set according to the weight, sex and age of the patient, and the patient can train and punch cards every day according to the expected vital capacity, so that the improvement of the lung function is promoted.
The predicted formula for the PEF value is as follows:
the adult formula is: male: PEFL/min=76.5+20.4×a-0.41×a2+0.002×a3+1.19×h
Female: PEFL/min=282.0+1.79×a-0.046×a2+0.68×h
The formula for children is: male: PEFL/min=5.29×h-427.1
Female: PEFL/min=4.94×h-399.8
Wherein A refers to age, and the unit is age; h refers to height in cm.
The invention discloses an intelligent monitoring watch suitable for asthma patients and a using method thereof, and the intelligent monitoring watch comprises the following specific implementation processes: firstly, the VCC interface of a pressure sensor 14 is connected with the 5V interface of a processor 11, the GND interface of the pressure sensor 14 is connected with the GND interface of the processor 11, the S interface is connected with the VCC interface of a potentiometer sensor 25, the GND interface of the potentiometer sensor 25 is connected with the GND interface of an AD conversion module 13, the VCC interface of the AD conversion module 13 is connected with the SCL of the processor 11, the GND interface of an indication module 16 is connected with the GND interface of the processor, the G interface of the indication module 16 is connected with the G17 interface of the processor 11, one end of a power module 18 is connected with the 5V interface of the processor 11, and the other end is connected with the GND interface of the processor 11; the pressure sensor 14 is provided with pressure through the blowing nozzle 5, when the pressure is lower than a certain threshold value, the red LED lamp is lighted, the light intensity can be increased along with the increase of the pressure value, and then the intelligent monitoring watch is used according to the using method of the intelligent monitoring watch.
According to the invention, the blow nozzle 5 and the pressure sensor 14 for monitoring the peak flow velocity are arranged on the watch, a person to be tested blows air into the blow nozzle by force so that the pressure sensor 14 reads a certain pressure, and the peak flow velocity is accurately measured by continuous experimental calibration; collecting pulse waveforms of the wrist part by adopting a photoelectric sensor 15, and calculating to obtain blood pressure information of a patient according to a formula; according to the invention, the peak flow velocity meter is combined with the intelligent watch, the peak flow velocity of the expired breath of the patient suffering from asthma, namely PEF measurement, is used for monitoring the degree of the severity of the asthma, so that early warning is achieved, the frequency of acute attack of the asthma is effectively reduced, and the patient is assisted to perform respiratory function exercise.
The wrist strap is convenient to wear and high in comfort, is suitable for wrists with different thicknesses, and reduces uncomfortable feeling for asthma patients; the invention has the capability of monitoring the physical condition of the asthmatic patient with high precision; the asthma-relieving health care product has the advantages that the asthma-relieving health care product is instant, the asthma patient needs to be helped in time during the attack period, and the asthma-relieving health care product can immediately detect and remind the patient or relatives and friends and medical staff; the watch is connected with the mobile terminal to transmit the monitored data to medical staff or relatives and friends so that the medical staff or relatives and friends can know the health condition of the patient at any time and adjust the treatment scheme in real time; the invention has individuation, provides individuation monitoring and reminding functions according to the illness state degree and the incentive of the asthma patient, so as to achieve the optimal treatment effect; the invention has stronger durability, the battery life of the watch needs to be long enough, and the watch can stably work in the long-time use process, thereby reducing the frequency of battery replacement or charging; the invention has reasonable design and is worth popularizing.
The invention and its embodiments have been described above with no limitation, and the actual construction is not limited to the embodiments of the invention as shown in the drawings. In summary, if one of ordinary skill in the art is informed by this disclosure, a structural manner and an embodiment similar to the technical solution should not be creatively devised without departing from the gist of the present invention.
Claims (9)
1. Intelligent monitoring wrist-watch suitable for asthma patient, its characterized in that: the intelligent monitoring watch comprises a dial plate (1) and a watchband (2), wherein the dial plate (1) comprises a shell (3), a screen (4), a blowing nozzle (5), a knob (6), keys (7), a charging port (8) and a control circuit board (9); the screen (4) is arranged on the front side surface of the shell (3), the blowing nozzle (5) is arranged below the screen (4), the blowing nozzle (5) is rotationally connected with the dial plate (1) through a rotating shaft (10), the knob (6) is arranged on the right side surface of the shell (3), the key (7) is arranged on the left side surface of the shell (3), the charging port (8) is arranged on the rear side surface of the shell (3), and the control circuit board (9) is arranged in the shell (3);
the control circuit board (9) comprises a processor (11), a Bluetooth module (12), an AD conversion module (13), a pressure sensor (14), a potentiometer sensor (25), a photoelectric sensor (15), an indication module (16), a storage module (17) and a power module (18), wherein the output end of the pressure sensor (14) is electrically connected with the input end of the potentiometer sensor, the output end of the potentiometer sensor and the output end of the photoelectric sensor (15) are respectively electrically connected with the input end of the AD conversion module (13), the output end of the AD conversion module (13) is electrically connected with the input end of the processor (11), the output end of the processor (11) is respectively electrically connected with the input end of the indication module (16), the input end of the storage module (17) and the input end of the screen (4), the power module (18) provides power required by the intelligent monitoring watch, and the charging port (8) is electrically connected with the power module (18).
The watch is characterized in that a watch buckle (19) is arranged on the watch strap (2), the watch strap (2) comprises a first watch strap (20) and a second watch strap (21), one end of the first watch strap (20) is connected with the dial plate (1), the other end of the first watch strap is connected with the watch buckle (19), one end of the second watch strap (21) is connected with the dial plate (1), and the other end of the second watch strap penetrates through the watch buckle (19).
2. A smart watch adapted for use with asthmatic patients as defined in claim 1, wherein: the shell (3) is provided with a placing groove (22), the rotating shaft (10) is arranged at the bottom of the placing groove (22), and the blowing nozzle (5) is clamped on the rotating shaft (10) and is detachably connected with the rotating shaft (10).
3. A smart watch adapted for use with asthmatic patients as defined in claim 2, wherein: the pressure sensor (14) is arranged on the rotating shaft (10), and when the blowing nozzle (5) rotates to be vertical to the dial plate (1), the pressure sensor (14) appears at the bottom of the blowing nozzle (5); the photoelectric sensor (15) is arranged on the rear side surface of the shell (3).
4. A smart watch adapted for use with asthmatic patients as defined in claim 3, wherein: the dial plate (1) bottom is equipped with first fixed knot (23), dial plate (1) top is equipped with second fixed knot (24), first watchband (20) one end is fixed in first fixed knot (23), second watchband (21) one end is fixed in second fixed knot (24).
5. A smart watch adapted for use with asthmatic patients as defined in claim 4, wherein: the shell (3) is made of rose gold frosted metal.
6. A smart watch adapted for use with asthmatic patients as defined in claim 5, wherein: the processor (11) adopts a raspberry group convenient for agile development, and the Bluetooth module (12) is a Bluetooth communication module on the raspberry group SOC; the processor (11) sends control data to the mobile terminal through the Bluetooth module; the storage module (17) is used for storing an SD card; the indication module (16) is used for indicating an LED lamp; the AD conversion module (13) is a PCF8591AD module; the pressure sensor (14) is a resistive film pressure sensor.
7. The smart watch for an asthmatic patient of claim 6, wherein: the mobile terminal comprises a patient end, a medical care end and a relatives end.
8. A method of using a smart watch comprising the smart watch of claims 1-7 adapted for use with asthmatic patients, characterized in that: the using method of the intelligent monitoring watch is as follows:
the method for detecting the lung function of a patient is as follows:
and (3) primary detection: when the patient detects for the first time, the patient needs to be filled with the sex, the height and the age of the patient, so that the normal PEF value of the patient is obtained;
the correct detection method comprises the following steps: when the device is used for detection, a standing position and a sitting position are adopted, a subject rapidly and deeply sucks one breath to the total lung amount position, the mouth of the subject is rapidly contained in the mouth and is tightly covered by the lips, no air leakage is avoided, and the gas in the lung is immediately exhaled by using the maximum strength and the maximum speed; the whole expiration is finished at one time, the middle part cannot be stopped, the neck keeps a neutral position, and the trachea is prevented from being pressed due to the forward bending and backward tilting of the neck; checking for at least 3 times, if the difference between the measured values of 3 times is too large, paying attention to whether the checking method is correct or not, repeating for a plurality of times, so that the difference between the optimal 3 times is less than 5%, or the difference between the measured values of the optimal 2 times in 3 times is less than 40L/min, and taking the highest value as PEF;
detection time: routine inspection: detecting for 2 times in day and night, and after getting up and before sleeping; checking as required: measuring when the symptom appears in the subject, and measuring before and after the exercise and the environmental factor exposure stimulus respectively; checking before and after administration: PEF was measured before and after inhalation of the quick-acting bronchodilators, and the PEF was monitored for days and weeks using controlled drug to assess airway reversibility and drug efficacy;
detecting the effect of PEF on expiratory airflow limitation:
judging by adopting the percentage of the PEF actual measurement value to the normal predicted value, if the PEF is more than or equal to 80 percent of the predicted value, prompting that the PEF is normal or has no expiratory airflow limitation, and distinguishing that the asthma of the patient is well controlled as a green area; PEF accounts for 60% -80% of the expected value, and indicates that the light-moderate expiratory airflow is limited, and the patient has asthma symptoms, and if the patient has symptoms of nocturnal attack, cough, chest distress, wheezing and limited activity, the medication is regulated according to the situation; PEF accounts for less than 60% of the expected value, and indicates that the expiratory airflow limitation degree is heavy, and the expiratory airflow limitation is red, so that the patient has asthma symptoms at rest and limited activity and needs to take medicine immediately;
detecting the effect of PEF variability on variable expiratory airflow limitation:
daily detection: screening measured PEFs every 24 hours to obtain PEFMAX and PEFMIN, and calculating to obtain a daily variation rate PEF24 hours; if PEF24h is less than 10%, sending 'your disease control is stable' to the patient end; if PEF24h is more than 10%, sending 'your condition is unstable, and suggesting to increase one medicine inhalation'; if PEF24h is more than 20%, sending' your illness state is unstable, suggesting to increase one medicine inhalation, and suggesting to consult doctors;
weekly testing: screening the measured PEFs for 1 week to obtain PEF24hMAX and PEF24hMIN, and calculating to obtain Zhou Bianyi-rate PEF1wk; if PEF1wk is less than 10%, sending 'your disease control is stable, and a doctor can be consulted to adjust the dosage' to a patient end; if PEF1wk is more than 10%, sending a 'maintaining current medication' to a patient end;
monthly detection: screening the measured PEF1wk for 1 month to obtain PEF1wkMAX and PEF1wkMIN, calculating to obtain a month variation rate PEF1mon, and if the PEF1mon is less than 10%, sending a patient xx to be regulated medication to a doctor terminal; if PEF1mon is more than 20%, sending ' unstable illness state ' to a patient end, and consulting with a doctor as soon as possible ';
detecting and reminding functions:
according to the state of illness of patients, adjusting the interval time T of each breath detection amount examination; if the patient respiratory gas quantity is not detected in the T, sending a proposal of measuring the maximum respiratory gas quantity as soon as possible to an intelligent bracelet end and sending the proposal to a mobile terminal of the patient or family members;
respiratory exercise function:
the expected vital capacity is set according to the weight, sex and age of the patient, and the patient can train and punch cards every day according to the expected vital capacity, so that the improvement of the lung function is promoted.
9. The method for using an intelligent monitoring watch according to claim 8, wherein: the predicted formula for the PEF value is as follows:
the adult formula is: male: PEF (L/min) =76.5+20.4×a-0.41×a2+0.002×a3+1.19×h
Female: PEF (L/min) =282.0+1.79×a-0.046×a2+0.68×h
The formula for children is: male: PEF (L/min) =5.29×h-427.1
Female: PEF (L/min) =4.94×h-399.8
Wherein A refers to age, and the unit is age; h refers to height in cm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310485451.8A CN116421170A (en) | 2023-05-04 | 2023-05-04 | Intelligent monitoring watch suitable for asthma patient and use method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310485451.8A CN116421170A (en) | 2023-05-04 | 2023-05-04 | Intelligent monitoring watch suitable for asthma patient and use method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116421170A true CN116421170A (en) | 2023-07-14 |
Family
ID=87087233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310485451.8A Pending CN116421170A (en) | 2023-05-04 | 2023-05-04 | Intelligent monitoring watch suitable for asthma patient and use method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116421170A (en) |
-
2023
- 2023-05-04 CN CN202310485451.8A patent/CN116421170A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3699469B2 (en) | Respiratory function sensor device | |
| CN103529684B (en) | For automatically surveying intelligent health wrist-watch and the intelligent health system of record health data | |
| CN204192596U (en) | Size intelligent healthcare instrument | |
| CN200987666Y (en) | Portable sleep monitor | |
| TWI512665B (en) | Ward cloud system | |
| CN109937000A (en) | Portable spirometer | |
| CN105361858B (en) | A kind of method and wearable device of blood pressure data processing | |
| CN203776881U (en) | Novel wearable health monitoring device | |
| CN106175770A (en) | Apneic determination methods and system during a kind of sleep | |
| TWM444565U (en) | Electronic vital-sign system with manually entering vital-sign data function | |
| WO2016120875A1 (en) | Orally inserted probe and method for measuring vital signs | |
| US11723542B2 (en) | Advanced respiratory monitor and system | |
| CN107874765A (en) | Medical bracelet and method of self compensation with self-compensating function | |
| CN104739391A (en) | Portable buckle type health monitoring device | |
| CN202821356U (en) | Pressure differential electronic peak current meter with wireless transmission function | |
| CN102713916B (en) | BODE index measurement | |
| CN116421170A (en) | Intelligent monitoring watch suitable for asthma patient and use method thereof | |
| CN201453268U (en) | Remote respiration monitoring medical system | |
| CN201409916Y (en) | Individual physical index remote monitoring system | |
| CN110200632A (en) | A kind of Portable lung function detecting instrument | |
| US20230028914A1 (en) | Characterization of the nasal cycle | |
| CN100396241C (en) | Method of monitoring respiration using breast impedance | |
| CN204468059U (en) | A kind of portable button health monitoring device | |
| CN106236096A (en) | A kind of small handheld spirometer | |
| CN209032322U (en) | A kind of novel wearable obstructive sleep apnea syndrome early warning system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |